Written questions by Whittome.

Commonwealth and Development Affairs, what recent discussions she has had with her Pakistani counterpart on the a) health and b) access to medical treatment of Imran Khan.

I refer the Hon Member to the answer given on 6 March to Question HL14686.

Commonwealth and Development Affairs, what representations her Department has made to the Government of Azerbaijan regarding the detention of Ali Karimli; and whether she will call for his immediate release.

The UK continues to monitor the human rights situation in Azerbaijan closely. On 4 December, senior officials from our Embassy in Baku raised this case with senior members of the Azerbaijani Government, including ensuring due legal process and where necessary access to medical care in accordance with Azerbaijan's international obligations and commitments.

Innovation and Technology, what assessment he has made of the potential benefits of making digital watermarking of AI mandatory.

The government continues to explore the feasibility of technical solutions for the labelling of AI-generated content to support transparency, such as through the Deepfake Detection Challenge.AI is a general-purpose technology with a wide range of applications, which is why the government believes that most AI systems should be regulated at the point of use. In response to the AI Action Plan, the government committed to work with regulators to boost their capabilities. The government has been clear that we will legislate where needed, but we will do so on the basis of evidence where any serious gaps are.

What assessment she has made of the potential impact of generative AI on academic standards in higher education.

Universities are independent, autonomous bodies responsible for designing and implementing their own artificial Intelligence (AI) policies. They are already responding to the opportunities and challenges AI presents.The Office for Students (OfS) set out its approach to the use of AI in higher education (HE) in June 2025. The approach can be found here: https://www.officeforstudents.org.uk/news-blog-and-events/blog/embracing-innovation-in-higher-education-our-approach-to-artificial-intelligence/.Providers are responsible for detecting and preventing academic misconduct, including misuse of AI, in line with the OfS’ regulatory framework. Providers that fall below these standards could be subject to regulatory action.The government is committed to ensuring that AI is not used to undermine high academic standards in HE. As set out in the Post-16 education and skills white paper, the department will support the OfS to assess the impact of artificial intelligence, including how students are using it in assessments, to ensure the integrity of HE assessments and qualifications is not compromised.

What steps his Department is taking to support the safety and appropriate care of patients with suspected craniocervical instability; what plans he has to improve access to appropriate imaging and specialist clinical review for such patients, including those with Ehlers-Danlos syndrome; and what assessment he has made of the potential merits of using patients’ lived experience to inform future policy development and service provision in this area.

Decisions on the assessment, diagnosis, and management of suspected craniocervical instability (CCI) are made by National Health Service clinicians on a case‑by‑case basis, drawing on established neurological, neurosurgical, rheumatology, and pain pathways. The Department has not issued specific national guidance on CCI, including in patients with Ehlers–Danlos syndromes (EDS). Responsibility for designing and commissioning pathways for rare or complex conditions rests with integrated care boards (ICBs), which are best placed to plan services that reflect local needs and available specialist expertise.Patients with symptoms suggestive of CCI may be referred for appropriate diagnostic imaging, such as magnetic resonance imaging or computed tomography scanning, where clinically indicated. Access to imaging continues to expand through the Government’s programme of community diagnostic centres, which is increasing diagnostic capacity and supporting earlier identification of complex conditions as part of the wider 10‑Year Health Plan.Where specialist clinical review is required, referral decisions are made by NHS clinicians, who can access expertise across neurology, neurosurgery, and associated sub-specialties. ICBs are responsible for ensuring that local pathways support timely referral to the most appropriate service.The Department recognises the value of patients’ lived experience in improving the design of services for complex conditions. Department officials are working with patient groups to identify service gaps, improve equity of access, and inform future service development. This approach helps ensure that the needs and experiences of patients with suspected CCI, including those with EDS, are reflected in wider policy work.

If she will make it her policy to allow migrant nurses who are not employed by the NHS to qualify for indefinite leave to remain after 5 years.

The Government recognises and values the important contribution that nurses make to the UK and our National Health Service.The earned settlement public consultation ran for 12 weeks and closed on 12 February 2026. We are now reviewing and analysing all responses received. This analysis will help inform the development of the final earned settlement model, including consideration of any potential exemptions or transitional measures for those already on a pathway to settlement.Once the final model has been decided, the Government will communicate the outcome publicly. As with all significant policy changes, the proposals will be subject to both an economic impact assessment and equality impact assessment which we will publish as well as the Government’s response in due course.

Communities and Local Government, what assessment he has made of the potential merits of allowing migrants with settled status to vote in general elections and referenda.

The Government has no plans to change the voting rights of foreign nationals. There are no set rules regarding who can vote in a UK-wide referendum. Instead, the franchise for each referendum is determined on a case-by-case basis by Parliament in the legislation providing for that referendum.

If his Department will make an assessment of the potential merits of including international medical graduates who are GMC-registered and who have at least two years’ NHS experience by 5 March 2026 in the prioritisation for specialty training.

The Medical Training (Prioritisation) Act 2026, which received Royal Assent on 5 March 2026, prioritises United Kingdom medical graduates and other doctors with significant National Health Service experience for specialty training places.For specialty training places starting in 2026, immigration statuses are being used as a practical proxy to capture applicants who are most likely to have significant experience working in the health service in the UK.From 2027, immigration status will no longer automatically determine priority for specialty training. Instead, we are able to make regulations to specify any additional groups who will be prioritised by reference to criteria indicating significant experience as a doctor in the health service, or by reference to immigration status. The Department will work with NHS England, the devolved administrations, and other partners on how best to define and evidence significant NHS experience as part of the development of those regulations.

What assessment he has made of the potential impact of current waiting times on decisions on claims for Attendance Allowance; and whether he will take steps to reduce the target processing time from up to 12 weeks, particularly for claimants undergoing active cancer treatment such as chemotherapy.

The Department keeps Attendance Allowance processing times under review and recognises the importance of timely decisions for older people, including those undergoing significant medical treatment. Through our wider Service Modernisation programme, we have taken steps to speed up and streamline the processing of new Attendance Allowance claims. We are now working to a target of clearing 90% of new claims within 30 days, and current performance shows that the majority of claims are being cleared within around 3–4 weeks, supported by increasing uptake of the new digital application route. For customers who are nearing the end of life, we operate a dedicated fast-track process under the Special Rules for End of Life, where claims are prioritised and typically cleared within 8 days. The extension of the end of life definition from 6 months to 12 months ensures more people with advanced conditions can benefit from this expedited process.

What steps he is taking to ensure that people with substance use issues can access specialist inpatient detox treatment.

Local authorities are responsible for commissioning drug and alcohol treatment services according to local need as part of their public health responsibilities, and this includes the provision of inpatient detoxification services.In line with recommendations in Dame Carol Black’s independent review of drug treatment and recovery, the Department created a distinct grant to support and expand inpatient detoxification for people who use drugs and alcohol. The £10 million a year grant ran between 2022/23 and 2024/25, before being consolidated into the Drug and Alcohol Treatment and Recovery Improvement Grant in 2025/26. Investment in inpatient detoxification services will continue beyond 2026. The Government has committed over £13.45 billion across three years through the Public Health Grant, including £3.4 billion ringfenced for drug and alcohol prevention, treatment, and recovery, which includes funding for inpatient detoxification. This multi-year funding provides greater certainty for local areas as they plan and sustain services.

What steps he is taking to ensure that patient experience data and intelligence is independently aggregated and analysed following the abolition of local Healthwatch.

Following the abolition of local Healthwatch, our proposals are that integrated care boards (ICBs) and local authorities (LAs) will have the responsibility for gathering views, and feedback from local people about health and social care services respectively in their area. ICBs and LAs will be required to take these views into account when looking at their commissioning strategies to ensure these meet the needs of local people. They will also be required to demonstrate that they have done so. However, these proposals require primary legislation. The timing of this is subject to the will of Parliament and will happen when parliamentary time allows.

If he will ensure that human, qualitative patient insight is not displaced by digital, survey-based and institution-led feedback once local Healthwatch is abolished.

As set out in the Dash Review of the patient safety landscape published in July 2025, and in the 10-Year Health Plan, the statutory functions of local Healthwatch bodies will be transferred to integrated care boards (ICBs) for health, and to local authorities (LAs) for social care.Both ICBs and LAs will be required to demonstrate how they have gathered patient and user feedback from local people including those who do not have access to digital platforms, those who are less proficient with technology, and people for whom English is a second language.

What assessment he has made of the potential benefits of including inflammatory bowel disease on the list of medical conditions which are entitled to a medical exemption certificate.

There are currently no plans to add inflammatory bowel disease to the list of medical conditions that entitle someone to apply for a medical exemption certificate which exempts the holder from paying the National Health Service prescription charge.

What assessment his Department has made of the potential impact of the availability of NHS provision on the number of patients with Cranio-Cervical Instability who are seeking (a) diagnosis and (b) surgical treatment overseas.

The Department recognises that Ehlers–Danlos syndromes (EDS) and associated cranio‑cervical instability (CCI) are complex conditions that can be challenging to diagnose and manage, and we acknowledge the concerns raised by patients and clinicians about variation in expertise and access to appropriate care.Care for CCI is managed within existing specialised neurology and spinal pathways, delivered in centres with the appropriate expertise. NHS England works with clinical experts and integrated care boards to ensure that provision reflects the best available evidence and supports patients with complex connective‑tissue and neurological presentations. Decisions on surgical interventions for CCI must be based on individual clinical assessment, the strength of available evidence for benefit, and consideration of potential risks.Once qualified, healthcare professionals are responsible for ensuring their own clinical knowledge remains up to date, and for identifying learning needs as part of their continuing professional development. Clinical teams are expected to use the best available evidence and follow national guidance when assessing and managing patients with complex connective tissue disorders.The Department continues to engage with patient groups, charities, and Members of Parliament on the issues facing people with EDS and CCI. Insights from this engagement, including on the barriers patients encounter in accessing National Health Services, are informing our ongoing consideration of what further action may be needed to strengthen referral routes, support the dissemination of clinical resources, and consider where further system support may improve diagnostic confidence and care coordination.The Department is aware of a number of individual cases where patients with suspected CCI have travelled overseas for imaging or surgery not routinely available in the NHS.

What steps his Department is taking to improve a) (a) the diagnosis of, (b) clinician training on and (c) access to treatment for patients with Ehlers-Danlos Syndromes and associated Cranio-Cervical Instability.

The Department recognises that Ehlers–Danlos syndromes (EDS) and associated cranio‑cervical instability (CCI) are complex conditions that can be challenging to diagnose and manage, and we acknowledge the concerns raised by patients and clinicians about variation in expertise and access to appropriate care.Care for CCI is managed within existing specialised neurology and spinal pathways, delivered in centres with the appropriate expertise. NHS England works with clinical experts and integrated care boards to ensure that provision reflects the best available evidence and supports patients with complex connective‑tissue and neurological presentations. Decisions on surgical interventions for CCI must be based on individual clinical assessment, the strength of available evidence for benefit, and consideration of potential risks.Once qualified, healthcare professionals are responsible for ensuring their own clinical knowledge remains up to date, and for identifying learning needs as part of their continuing professional development. Clinical teams are expected to use the best available evidence and follow national guidance when assessing and managing patients with complex connective tissue disorders.The Department continues to engage with patient groups, charities, and Members of Parliament on the issues facing people with EDS and CCI. Insights from this engagement, including on the barriers patients encounter in accessing National Health Services, are informing our ongoing consideration of what further action may be needed to strengthen referral routes, support the dissemination of clinical resources, and consider where further system support may improve diagnostic confidence and care coordination.The Department is aware of a number of individual cases where patients with suspected CCI have travelled overseas for imaging or surgery not routinely available in the NHS.

Communities and Local Government, what recent steps he has taken towards bringing the provisions in the Freehold Reform Act 2024 into force.

I refer the hon. Member to the answer given to Question UIN 103549 on 14 January 2026 and to the Written Ministerial Statement I made on 27 January 2026 (HCWS1278).

Commonwealth and Development Affairs, what steps she is taking to help ensure UK-registered charities can continue operating in Palestine under Palestinian Authority registration.

Regarding the registration of non-governmental organisations to operate in Gaza, I refer the Hon Member to the statement I made to the House on 5 January, and to the joint statement made by the Foreign Secretary and a number of her counterparts on 30 December, which can be found here: https://www.gov.uk/government/news/jointstatementon-the-gaza-humanitarian-response.

What assessment his Department has made of the potential impact of the Medical Training (Prioritisation) Bill on British citizens who have already commenced undergraduate medical degrees overseas on the understanding that they would be able to return to the UK to complete their Foundation Programme; and what plans he has to implement transitional protections and assurances to safeguard their training prospects and future careers in the NHS.

Subject to the parliamentary passage of the bill, British citizens who have graduated from medical schools outside of the United Kingdom will not be prioritised for foundation training places if they spent the majority of their time studying outside the British Islands.The Government does not plan to implement transitional protections or assurances in relation to these applicants. Prioritisation does not mean exclusion. Non-prioritised graduates will still be able to apply for foundation training places, and they will be offered places if vacancies remain after prioritised applicants have received offers.

What consideration his Department has given to introducing transitional arrangements for the implementation of UK graduate prioritisation in medical specialty recruitment for the 2025–26 recruitment cycle; and whether he will review the decision to assess applicants’ immigration or settlement status at the point of application rather than at the point of job offer, in cases where applicants will have Indefinite Leave to Remain by the time offers are made.

The Government does not plan to introduce transitional arrangements for the implementation of the Medical Training (Prioritisation) Bill.For 2026 specialty training posts we have used immigration status as a reasonable proxy for National Health Service experience. Subject to parliamentary passage, the bill prioritises applicants at offer stage based on their immigration status at that point. Applicants will be able to update their application status where it has changed since they made their application. For specialty training posts starting from 2027 onwards, the immigration status category will not apply automatically. Instead, we will be able to make regulations to specify any additional groups who will be prioritised by reference to criteria indicating significant experience as a doctor in the health service, or by reference to immigration status. We will set out next steps on these regulations in due course.

Commonwealth and Development Affairs, what discussions she has had with her (a) Chinese and (b) Japanese counterpart on the maintenance of peace and international law in East Asia.

The Foreign Secretary has emphasised the importance of regional stability in her discussions with Chinese and Japanese counterparts. The Prime Minister also recently visited China and Japan and held relevant discussions on regional security with both leaders.